SCHEMBL7657241

SCHEMBL7657241

CCOC(=O)c1ccc(NC(C)=O)c(NCc2ccc(OCC3CCCCC3)cc2Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.47
KMT2A Q03164 1/20 0.41
PTGER4 P35408 1/20 0.40
ACACB O00763 3/20 0.39
PARP10 Q53GL7 4/20 0.39
PARP15 Q460N3 3/20 0.39
CYP1A2 P05177 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 3/20 0.37
LMNA P02545 1/20 0.36
PPM1D O15297 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6301182 0.87 KMT2A (0.47) ALOX15KMT2ACYP1A2RAB9AALDH1A1
SCHEMBL7652135 0.81 ALOX15 (0.49) ALOX15KMT2APTGER4CYP1A2RAB9A
SCHEMBL6301593 0.81 HDAC1 (0.54) ALOX15KMT2ACYP1A2RAB9AALDH1A1
SCHEMBL7650334 0.81 ALDH1A1 (0.55) ALOX15KMT2APTGER4CYP1A2RAB9A
SCHEMBL6301558 0.79 KMT2A (0.48) ALOX15KMT2APTGER4CYP1A2RAB9A
SCHEMBL6301341 0.79 KMT2A (0.48) ALOX15KMT2APTGER4CYP1A2RAB9A
SCHEMBL6430006 0.77 KMT2A (0.47) ALOX15KMT2ACYP1A2RAB9AALDH1A1
SCHEMBL6301145 0.77 KMT2A (0.47) ALOX15KMT2ACYP1A2RAB9AALDH1A1
SCHEMBL6303883 0.77 RAB9A (0.59) ALOX15KMT2ACYP1A2RAB9AALDH1A1
SCHEMBL6307818 0.77 ALOX15 (0.45) ALOX15KMT2ACYP1A2RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed